|
⚲
|
| Nanomedex Pharmaceuticals Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001448282 |
| Sale | 2009-05-19 ($0.5 M Offered, $0.5 M Sold) |
| Fund | |
| Phone | 6088779933 |
| Address | 5520 Nobel Drive Fitchburg, 53711 |
| Source | [EDGAR] |
| Fund AUM and Sold ($k) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| David Cooper | |
| Timothy Morey | |
| Kenneth Johnson | |
| Jeffrey Girard | |
| Nikolaus Gravenstein | |
| Mark Nottoli |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Fund XXXVIII, a series of SCVC Advisors, LP
✚
|
0.0 | |
|
FURE Hiroshi
✚
|
0.0 | |
|
Furlong Mark F
✚
|
0.0 | |
|
Furlong Matthew
✚
|
0.0 | |
|
Furlong Stephen
✚
|
0.0 | |
|
Furnished Living LLC
✚
|
0.0 | |
|
Furr Randy W
✚
|
0.0 | |
|
Fury Capital Management LLC
✚
|
0.0 | |
|
Fusar Technologies Inc
✚
|
0.0 | |
|
Fund XXXVII, a series of SCVC Advisors, LP
✚
|
0.0 |